PulseAugur
EN
LIVE 23:20:28

CDC acting director criticizes vaccine study methodology

Jay Bhattacharya, the acting director of the CDC, has reportedly blocked the publication of a study on COVID-19 vaccine effectiveness due to its methodology. The study, which used the test-negative design, indicated that the season's vaccines were about half as effective at preventing hospitalizations in healthy adults. Bhattacharya criticized the study's design as "crap" and "logistically ridiculous," though the test-negative design has been a standard method for estimating vaccine effectiveness for two decades. AI

RANK_REASON Article discusses a controversy surrounding a public health official's critique of a study's methodology, rather than a new release or core research finding.

Read on Forbes — Innovation →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

CDC acting director criticizes vaccine study methodology

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Commentary
Article discusses a controversy surrounding a public health official's critique of a study's methodology, rather than a new release or core research finding.
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
policy, other
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
Low
Off-topic or adjacent — cluster remains reachable but doesn't surface in AI-industry rankings.
Story freshness
138 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [1]

  1. Forbes — Innovation TIER_1 English(EN) · John Drake, Contributor ·

    Acting CDC Director Jay Bhattacharya Called A Vaccine Study Design 'Crap.' What The Test-Negative Design Is And How We Know Whether Vaccines Measured With It Are Effective

    Jay Bhattacharya dismissed the test-negative design as 'crap.' The biostatistics literature tells a different story.